(VIANEWS) – NASDAQ Composite ended the session with BioNTech SE jumping 8.23% to $280.98 on Thursday, after five successive sessions in a row of gains. NASDAQ Composite rose 0.36% to $14,684.60, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Today’s last reported volume for BioNTech SE is 5546980, 79.94% above its average volume of 3082660.
BioNTech SE’s last close was $259.61, 8.56% below its 52-week high of $283.92.
The company’s growth estimates for the ongoing quarter and the next is 2084.4% and 917.8%, respectively.
BioNTech SE’s Revenue
Year-on-year quarterly revenue growth grew by 7294.9%, now sitting on 2.5B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
BioNTech SE’s stock is considered to be oversold (<=20).
BioNTech SE’s Stock Yearly Top and Bottom Value
BioNTech SE’s stock is valued at $280.98 at 17:05 EST, under its 52-week high of $283.92 and way higher than its 52-week low of $54.10.
BioNTech SE’s Moving Average
BioNTech SE’s value is way higher than its 50-day moving average of $224.98 and way above its 200-day moving average of $155.71.
More news about BioNTech SE (BNTX).